These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36341461)

  • 41. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
    Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs.
    Alkanfari I; Freeman KB; Roy S; Jahan T; Scott RW; Ali H
    Cells; 2019 Apr; 8(4):. PubMed ID: 30987258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D; Nigolian H; Czarnetzki C; Harr T
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Authentic and Ectopically Expressed MRGPRX2 Elicit Similar Mechanisms to Stimulate Degranulation of Mast Cells.
    Lazki-Hagenbach P; Ali H; Sagi-Eisenberg R
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-pseudo-allergy effect of isoliquiritigenin is MRGPRX2-dependent.
    Hou Y; Che D; Ma P; Zhao T; Zeng Y; Wang N
    Immunol Lett; 2018 Jun; 198():52-59. PubMed ID: 29684393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.
    Chompunud Na Ayudhya C; Amponnawarat A; Ali H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture.
    Babina M; Wang Z; Artuc M; Guhl S; Zuberbier T
    Exp Dermatol; 2018 Nov; 27(11):1298-1303. PubMed ID: 30091263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRGPRX2 and Immediate Drug Hypersensitivity: Insights From Cultured Human Mast Cells.
    Elst J; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; Hagendorens MM; Van Tendeloo V; Maurer M; Campillo-Davo D; Timmermans JP; Pintelon I; Ebo DG
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):489-499. PubMed ID: 32732181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs.
    Ali H
    Curr Opin Immunol; 2021 Oct; 72():65-71. PubMed ID: 33857758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.
    McNeil BD; Pundir P; Meeker S; Han L; Undem BJ; Kulka M; Dong X
    Nature; 2015 Mar; 519(7542):237-41. PubMed ID: 25517090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells
    Amponnawarat A; Chompunud Na Ayudhya C; Ali H
    Front Immunol; 2021; 12():689410. PubMed ID: 34248979
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal-Regulated Kinase 1/2 Module in Human Skin Mast Cells.
    Wang Z; Franke K; Zuberbier T; Babina M
    J Invest Dermatol; 2022 Feb; 142(2):414-424.e8. PubMed ID: 34329659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.
    Mi YN; Ping NN; Cao YX
    Rev Physiol Biochem Pharmacol; 2021; 179():139-188. PubMed ID: 33479839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of G
    Wang Z; Franke K; Bal G; Li Z; Zuberbier T; Babina M
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gold induces a pseudo-allergic reaction via MRGPRX2 both in vitro and in vivo.
    Zeng Y; Wang J; Zhang Y; Ge S; Wu Y; Fan T; Wang N
    Cell Immunol; 2019 Jul; 341():103923. PubMed ID: 31076078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Store-Operated Calcium Entry via STIM1 Contributes to MRGPRX2 Induced Mast Cell Functions.
    Occhiuto CJ; Kammala AK; Yang C; Nellutla R; Garcia M; Gomez G; Subramanian H
    Front Immunol; 2019; 10():3143. PubMed ID: 32038646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roxithromycin inhibits compound 48/80-induced pseudo-allergy via the MrgprX2 pathway both in vitro and in vivo.
    Zhang Y; Wang J; Ge S; Zeng Y; Wang N; Wu Y
    Cell Immunol; 2020 Dec; 358():104239. PubMed ID: 33129497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol.
    Yuan F; Zhang C; Sun M; Wu D; Cheng L; Pan B; Li T; Che D
    Biomed Pharmacother; 2021 May; 137():111323. PubMed ID: 33524790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Multifaceted Mas-Related G Protein-Coupled Receptor Member X2 in Allergic Diseases and Beyond.
    Quan PL; Sabaté-Brescó M; Guo Y; Martín M; Gastaminza G
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MRGPRX2 and Adverse Drug Reactions.
    McNeil BD
    Front Immunol; 2021; 12():676354. PubMed ID: 34421893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.